Black Diamond Therapeutics
investment firm
Funding Round
Series B
Money Raised
$ 85M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Boxer Capital | - | Yes | - | Detail |
| New Enterprise Associates | - | Yes | - | Detail |
| RA Capital Management | - | Yes | - | Detail |
| Biotechnology Value Fund | - | - | - | Detail |
| Casdin Capital | - | - | - | Detail |
| City Hill Ventures | - | - | - | Detail |
| Deepfield | - | - | - | Detail |
| Invus | - | - | - | Detail |
| Janus Henderson Investors | - | - | - | Detail |
| Logos Capital | - | - | - | Detail |
| Nextech Invest | - | - | - | Detail |
| Perceptive Advisors | - | - | - | Detail |
| Roche Venture Fund | - | - | - | Detail |
| Versant Ventures | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Dec 12, 2018 | Series A | $ 20M | Versant Ventures | Detail |
| Mar 28, 2017 | Series Unknown | $ 7.10M | Detail |
